Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
10 2023
Historique:
received: 12 05 2023
revised: 07 07 2023
accepted: 18 07 2023
medline: 11 9 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

To scrutinize whether the high circulation of respiratory syncytial virus (RSV) observed in 2021-2022 and 2022-2023 was due to viral diversity, we characterized RSV-A and -B strains causing bronchiolitis in Rome, before and after the COVID-19 pandemic. RSV-positive samples, prospectively collected from infants hospitalized for bronchiolitis from 2017-2018 to 2022-2023, were sequenced in the G gene; phylogenetic results and amino acid substitutions were analyzed. Subtype-specific data were compared among seasons. Predominance of RSV-A and -B alternated in the pre-pandemic seasons; RSV-A dominated in 2021-2022 whereas RSV-B was predominant in 2022-2023. RSV-A sequences were ON1 genotype but quite distant from the ancestor; two divergent clades included sequences from pre- and post-pandemic seasons. Nearly all RSV-B were BA10 genotype; a divergent clade included only strains from 2021-2022 to 2022-2023. RSV-A cases had lower need of O The intense RSV peak in 2021-2022, driven by RSV-A phylogenetically related to pre-pandemic strains is attributable to the immune debt created by pandemic restrictions. The RSV-B genetic divergence observed in post-pandemic strains may have increased the RSV-B specific immune debt, being a possible contributor to bronchiolitis severity in 2022-2023.

Identifiants

pubmed: 37495189
pii: S0163-4453(23)00381-X
doi: 10.1016/j.jinf.2023.07.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

305-314

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: GUIDO ANTONELLI reports financial support was provided by EU funding within the NextGeneration EU-MUR PNRR. ANNA TERESA PALAMARA reports financial support was provided by Italian Ministry of Health.

Auteurs

A Pierangeli (A)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: alessandra.pierangeli@uniroma1.it.

R Nenna (R)

Department of Pediatrics and Infantile Neuropsychiatry, Sapienza University, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: raffaella.nenna@uniroma1.it.

M Fracella (M)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: matteo.fracella@uniroma1.it.

C Scagnolari (C)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: carolina.scagnolari@uniroma1.it.

G Oliveto (G)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: giuseppe.oliveto@uniroma1.it.

L Sorrentino (L)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: leonardo.sorrentino@uniroma1.it.

F Frasca (F)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: federica.frasca@uniroma1.it.

M G Conti (MG)

Department of Pediatrics and Infantile Neuropsychiatry, Sapienza University, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: mariagiulia.conti@uniroma1.it.

L Petrarca (L)

Department of Pediatrics and Infantile Neuropsychiatry, Sapienza University, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: laura.petrarca@uniroma1.it.

P Papoff (P)

Department of Pediatrics and Infantile Neuropsychiatry, Sapienza University, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: paola.papoff@uniroma1.it.

O Turriziani (O)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: ombretta.turriziani@uniroma1.it.

G Antonelli (G)

Virology Laboratory, Department of Molecular Medicine, Sapienza University, V.le Porta Tiburtina, 28, 00185 Rome, Italy. Electronic address: guido.antonelli@uniroma1.it.

P Stefanelli (P)

Department of Infectious Diseases, Istituto Superiore di Sanità, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: paola.stefanelli@iss.it.

A T Palamara (AT)

Department of Infectious Diseases, Istituto Superiore di Sanità, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: annateresa.palamara@iss.it.

F Midulla (F)

Department of Pediatrics and Infantile Neuropsychiatry, Sapienza University, V.le Regina Elena, 299, 00161 Rome, Italy. Electronic address: fabio.midulla@uniroma1.it.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH